Antibe Therapeutics Inc(Pre-Merger) ATBPF

New Investor Presentation (June 2021)

[IrishCanuck]

Not much different from April, but:

1) It looks like they added on Slide 7 that they're focussing on US, UK and EU4 (Germany, France, Italy and Spain)

2) I don't remember Slide 5 where they highlight two competitor drugs being withdrawn 

3) Slide 33 recent and upcoming milestones were updated

Maybe some of these were there before but I don't recall

[Doccole]

Interesting that LATAM is not a focus! Wonder if something is done already - GUD! That's my guess

[StockingUp21]

Why does this change every month. Can't keep focus maybe this is why deadlines never met.

[IrishCanuck]

Oh right, we should not provide updates of public companies... When we submit results to the FDA you'll be shouting "WHAT'S TAKING THE FDA SO LONG WE SUBMITTED THE DOCUMENTS YESTERDAY ALL YOU HAVE TO DO IS READ THE DOCUMENTS IT'S NOT THAT HARD AND MY $800 HAVE BEEN TIED UP IN ATE FOR SO LONG WAHHHHHHH" 

[MrMugsy]

Tough to say as it isn't a priority (right now) for Dan. ATE is focused on the Big Markets so maybe something in the future. I personally am more interested in GUD's Alzheimer drug purchase from Novartis and I'm stuck in the redacted agreement.  It shows a definite 3rd partner gaining control of the drug IP. It would be exciting if that was a 3-way partnership between GUD, ATE

[MrMugsy]

Thanks Irish ... Page 5 is older and some of the small font text was added lat time (or the update before). Page 6 ... Phase 3 still shows to be starting in the second half of 2021 - that's good to see ! Page 7 ... Yes ... nice to they are sharing their focus on the big geographies (super !) Curious to know if other geographies will be packaged with Japan, like other Asian countries and/or